Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 5,197-5,208 of 10,592
Drug study icon
TerminatedNCT01093963

Efficacy Study of Lisdexamfetamine to Treat Depression in bipolarity

This study exists to understand whether the medication Lisdexamfetamine is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In United States
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01393613

Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Colombia, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03423394

Efficacy study of Stress Check-Up

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDBehavioralOver 18 Years
Countries
United States
Sponsor
University of Washington
Condition
PTSD
Drug study icon
TerminatedNCT06431256

Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD

This study exists to understand whether the medication HLD200 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication HLD200 in practice and what may need to be adjusted.

In United States
ADHDDrugFrom 4 Years to 5 Years
Countries
United States
Sponsor
Ironshore Pharmaceuticals and Development, Inc
Condition
ADHD
Drug study icon
CompletedNCT01567527

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

This study exists to see whether the medication OPC-14597 can make care clearer and more responsive. Researchers are trying to understand whether the medication OPC-14597 can better prevent setbacks and support longer-term stability.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Japan, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
TerminatedNCT03896945

Efficacy, Safety, and Tolerability of AVP-786 for Negative Symptoms of Schizophrenia

This study exists to compare options and see whether the medication AVP-786 offers something meaningfully different. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Bulgaria, Poland
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.